Immunogenicity to biologics: processes, impact on efficacy and safety, and management strategy 2013 is a webinar that covers topics such as:
- Impact on efficacy and safety
- Overview on the processes and effects of immunogenicity
- Regulatory guidelines on immunogenicity of biologics; FDA, ICH, CHMP, EMEA
- Screening and confirmatory methods to measure immune responses
- Risk management strategy
Immunogenicity to biologics: processes, impact on efficacy and safety, and management strategy 2013 brings together:
- R&D investigators
- Executive management
- Pre-clinical and clinical
- Product development
- QA/ QC
- Regulatory affairs
- Consultants
- Marketing
- Training